MedTrace Logo

Effect of Add-on L-Arginine Therapy on Heart Failure Patients

NCT07394270 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-02-06

No results posted yet for this study

Summary

Heart failure is considered one of the greatest challenges globally. There are various treatment strategies for heart failure. L-Arginine is an amino acid that was found to have beneficial effect on vasculature. This study aims to study the benefits and side effects of using L-arginine on the patients with ejection fraction \<40%

Conditions

Interventions

DRUG

L-Arginine Powder

L-arginine 3 gm sachets are used twice daily

DRUG

Placebo

2 sachets of placebo are administered per day

Sponsors & Collaborators

  • Ain Shams University

    collaborator OTHER

  • German University in Cairo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-28
Primary Completion
2027-03-31
Completion
2027-07-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07394270 on ClinicalTrials.gov